Aspireon Wealth Advisors Rani Therapeutics Holdings, Inc. Transaction History
Aspireon Wealth Advisors
- $183 Million
- Q1 2023
A detailed history of Aspireon Wealth Advisors transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Aspireon Wealth Advisors holds 48,129 shares of RANI stock, worth $54,385. This represents 0.14% of its overall portfolio holdings.
Number of Shares
48,129
Previous 48,129
-0.0%
Holding current value
$54,385
Previous $284,000
12.68%
% of portfolio
0.14%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding RANI
# of Institutions
48Shares Held
3.76MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$802,1050.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$557,7490.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$506,7950.05% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$342,0990.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$329,2600.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $27.7M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...